Inventor · disambiguated record
Li Xiao
Also filed as: XIAO LI
24 granted patents·9 pending applications·144 citations·filing 2003–2025
94Inventor score
Files withMERCK SHARP & DOHME9MERCK SHARP & DOHME LLC8SCHERING CORP8AIR FORCE MEDICAL CENTER PLA1CHANGZHOU NO 4 PHARMACEUTICAL FACTORY CO LTD1
Top patents by PatentIndex Score
33 records- 0193US7807672B2Compounds that are ERK inhibitorsSCHERING CORP·Filed 2007·Granted Oct 5, 2010·16 cites·23 claims
- 0291US7700601B2Substituted indazoles of formula 1.0 that are kinase inhibitorsSCHERING CORP·Filed 2007·Granted Apr 20, 2010·38 cites·14 claims
- 0391US7511062B2Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitorsSCHERING CORP·Filed 2005·Granted Mar 31, 2009·31 cites·29 claims
- 0490US10221163B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·4 cites·67 claims
- 0587US9181632B1C.difficile toxin B CROP domain peptides, antibodies and complexes thereofMERCK SHARP & DOHME·Filed 2014·Granted Nov 10, 2015·12 cites·4 claims
- 0686US9708336B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 18, 2017·4 cites·26 claims
- 0786US8546404B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2007·Granted Oct 1, 2013·9 cites·76 claims
- 0886US7528132B2Kinase inhibitorsSCHERING CORP·Filed 2006·Granted May 5, 2009·14 cites·35 claims
- 0985US9839642B2Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Dec 12, 2017·3 cites·19 claims
- 1083US10544130B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jan 28, 2020·1 cites·20 claims
- 1182US12091405B2Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 17, 2024·2 cites·13 claims
- 1281US12152019B2Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 26, 2024·2 cites·20 claims
- 1377US10227331B2Metallo-β-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Mar 12, 2019·1 cites·26 claims
- 1477US7208311B2Catalytic domain of ADAM33 and methods of use thereofSCHERING CORP·Filed 2003·Granted Apr 24, 2007·4 cites·10 claims
- 1576US7776589B1Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)SCHERING CORP·Filed 2007·Granted Aug 17, 2010·2 cites·8 claims
- 1668US7335758B2Catalytic domain of ADAM33 and methods of use thereofSCHERING CORP·Filed 2006·Granted Feb 26, 2008·0 cites·11 claims
- 1765US8088611B2Kinase domain polypeptide of human protein kinase B gamma (AKT3)PRONGAY ANDREW J·Filed 2010·Granted Jan 3, 2012·1 cites·5 claims
- 1862US2025215464A1Engineered enzyme for preparing a hydroxylated indanone intermediate useful in the synthesis of belzutifanMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1960US2008199447A1Catalytic domain of adam33 and methods of use thereofSCHERING CORP·Filed 2007·Application pending·0 cites
- 2057US11207312B2Metallo-beta-lactamase inhibitors and methods of use thereofMERCK SHARP & DOHME·Filed 2018·Granted Dec 28, 2021·0 cites·14 claims
- 2156US2023174992A1Reductase enzymes and processes for making and using reductase enzymesMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2255US11992489B2Substituted tetrahydroquinoline compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted May 28, 2024·0 cites·20 claims
- 2354US2023201314A1Use of advanced platelet-rich fibrin in preparing medicament for treatment of diabetic foot ulcerAIR FORCE MEDICAL CENTER PLA·Filed 2022·Application pending·0 cites
- 2454US2025332157A1Solid composition of glp-1 receptor agonistHANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2554US2024002397A13-amino pyrrolidine and piperidine macrocyclic orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2653US11680060B2Bicycloheptane pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Granted Jun 20, 2023·0 cites·37 claims
- 2752US11352320B2Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jun 7, 2022·0 cites·14 claims
- 2851US11478461B2[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Oct 25, 2022·0 cites·19 claims
- 2948US12264134B2Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·0 cites·21 claims
- 3048US11801236B2Pramipexole hydrochloride oral liquidCHANGZHOU NO 4 PHARMACEUTICAL FACTORY CO LTD·Filed 2021·Granted Oct 31, 2023·0 cites·3 claims
- 3144US2025281604A1mRNA vaccine for porcine Deltacoronavirus, preparation method and application thereofJIANGSU ACAD AGRICULTURAL SCI·Filed 2025·Application pending·0 cites
- 3244US2020375987A1Metallo-beta-lactamase inhibitors and methods of use thereofPASTERNAK ALEXANDER·Filed 2018·Application pending·0 cites
- 3341US2007191604A1Novel compounds that are ERK inhibitorsCOOPER ALAN·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Li Xiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →